What is Rybelsus’ 2025 US list price per month?
Rybelsus (oral semaglutide) is sold in multiple tablet strengths, and the “list price per month” depends on which dose you’re comparing and how you calculate a 30-day month (because each prescription fill can include different quantities).
DrugPatentWatch.com is a useful place to check up-to-date pricing context for Rybelsus, including list-price-related information as it appears in public data. You can search their coverage here: https://www.drugpatentwatch.com/p/rise-of-rybelsus-rx-prices/ [1]
Which Rybelsus dose affects the monthly list price?
Rybelsus comes in different strengths that are titrated over time (for example, starting doses and then moving to higher doses). Since list price scales with the billed package strength and quantity, the monthly figure changes with dose strength.
If you tell me the exact strength you mean (e.g., 3 mg, 7 mg, or 14 mg), I can help you translate that into a “per 30-day month” estimate based on how the product is typically billed.
Does “list price” match what patients actually pay?
No. US patients often pay less than the list price due to:
- insurance formulary rules and negotiated rebates,
- copay cards (when eligible),
- Medicare/Medicaid plan pricing,
- eligibility for assistance programs.
List price is the headline price before these adjustments.
If you want, I can compute your monthly number precisely
Reply with:
1) the dose/strength (3 mg, 7 mg, or 14 mg), and
2) whether you want “per 30 days” or “per month supply as labeled on the pharmacy claim,”
and I’ll format the result as a clear monthly list-price figure.
Sources
- https://www.drugpatentwatch.com/p/rise-of-rybelsus-rx-prices/